D21008: CORE: CO monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients
Principal Investigator
Study Number
D21008
Summary
The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.
Phase
N/A
Contact
Available at the following location(s)
- Lebanon
View more details at ClinicalTrials.gov
Do you need help with some of the labels on this page?
Read our glossary of terms